Pyridostigmine Bromide Oral
1 NDC across 1 manufacturer|1 Generic,0 Brand
▸ More about this market▾ Less
Pyridostigmine Bromide Oral is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.56 to $0.56 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.56 – $0.56
per ML
7d Activity
avg +11.2% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novitium Pharma LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cholinesterase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing PYRIDOSTIGMINE BROMIDE ORAL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PYRIDOSTIGMINE 60 MG/5 ML SOLN | $0.5648 per ML | +11.19% |
Frequently Asked Questions
How many Pyridostigmine Bromide Oral products are on the market?
The Pyridostigmine Bromide Oral drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Pyridostigmine Bromide Oral?
NADAC reference prices for Pyridostigmine Bromide Oral range from $0.5648 to $0.5648 per ML.
Which manufacturers make Pyridostigmine Bromide Oral?
1 manufacturer lists Pyridostigmine Bromide Oral in NADAC. Ranked by number of NDCs, the largest are Novitium Pharma LLC (1).
How has the price of Pyridostigmine Bromide Oral changed recently?
Over the past 7 days, 1 Pyridostigmine Bromide Oral NDC rose and 0 fell, with a market-wide average change of +11.2%.